NCT03152708View on ClinicalTrials.gov

CAN008 Biomarker CD95 Ligand and CpG2 Methylation in Chinese Patients With Glioblastoma

UnknownOBSERVATIONAL
Enrollment

62

Participants

Timeline

Start Date

November 1, 2017

Primary Completion Date

December 1, 2017

Study Completion Date

December 31, 2017

Conditions
Glioblastoma
Sponsors
All Listed Sponsors
lead

CANbridge Life Sciences Ltd.

INDUSTRY